Ekaterina Schreiber‐Brynzak

Comparative studies of oxaliplatin-based platinum(<scp>iv</scp>) complexes in different in vitro and in vivo tumor models

Simone Göschl, Ekaterina Schreiber‐Brynzak, Verena Pichler et al. · Metallomics · 2017 · 65 citations · Full text

Chemoprevention Strategy, Vivo Tumor Models, Molecular Biology +20

Three-dimensional and co-culture models for preclinical evaluation of metal-based anticancer drugs

Ekaterina Schreiber‐Brynzak, Erik Klapproth, Christine Unger et al. · Investigational New Drugs · 2015 · 49 citations

Preclinical Drug Evaluation, Medicine, Rational Drug Design +8

Behavior of platinum(<scp>iv</scp>) complexes in models of tumor hypoxia: cytotoxicity, compound distribution and accumulation

Ekaterina Schreiber‐Brynzak, Verena Pichler, Petra Heffeter et al. · Metallomics · 2016 · 46 citations · Full text

LA-ICP-MS imaging in multicellular tumor spheroids – a novel tool in the preclinical development of metal-based anticancer drugs

Sarah Theiner, Ekaterina Schreiber‐Brynzak, Michael A. Jakupec et al. · Metallomics · 2016 · 40 citations

Nanotherapeutics, Engineering, Oncologic Imaging +21

Influence of reducing agents on the cytotoxic activity of platinum(<scp>iv</scp>) complexes: induction of G2/M arrest, apoptosis and oxidative stress in A2780 and cisplatin resistant A2780cis cell lines

Verena Pichler, Simone Göschl, Ekaterina Schreiber‐Brynzak et al. · Metallomics · 2015 · 38 citations · Full text